stockrowLiquidia Corporation
LQDA Healthcare Drug Manufacturers Specialty & Generic
Liquidia Corporation’s revenue for fiscal 2025 (year ended December 2025) was $158.3 million, up 1,031.2% from fiscal 2024.
- Revenue
- +1,842.7%
- EPS
- +271.4%
- Free cash flow
- +270.2%
- Total debt
- −9.04%
Quarter to June 2026, against a year earlier
Follow LQDA
Alert me
Liquidia Corporation (LQDA) Shares outstanding
Liquidia Corporation's shares outstanding at the end of fiscal 2025 was $86.1M, up 9.34% from $78.7M in fiscal 2024. At the end of the quarter to 30 June 2026 it was $101.4M. Over the past ten years it has ranged from $563.1K (fiscal 2017) to $86.1M (fiscal 2025) — the current reading is the highest in ten years. Liquidia Corporation ranks 32nd of 81 Drug Manufacturers Specialty & Generic companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $86.1M | 9.34% |
| FY2024 | $78.7M | 21.10% |
| FY2023 | $65.0M | 6.62% |
| FY2022 | $61.0M | 22.71% |
| FY2021 | $49.7M | 46.59% |
| FY2020 | $33.9M | 83.36% |
| FY2019 | $18.5M | 161.09% |
| FY2018 | $7.1M | 1,157.11% |
| FY2017 | $563.1K | (96.44%) |
| FY2017 | $15.8M | 0.00% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $101.4M | 0.28% |
| Mar 2026 | $101.1M | 17.49% |
| Dec 2025 | $86.1M | (0.32%) |
| Sep 2025 | $86.3M | 0.87% |
| 32 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | $335.7M |
| HIMS Hims & Hers Health, Inc. compare | $231.7M |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | $214.3M |
| SUPN Indivior Pharmaceuticals Inc. compare | $122.0M |
| AMLX Amylyx Pharmaceuticals, Inc. compare | $111.2M |
| LQDA Liquidia Corporation | $101.4M |
| LNTH Lantheus Holdings, Inc. compare | $68.4M |
| PBH Prestige Consumer Healthcare Inc. compare | $47.6M |
| RGC Regencell Bioscience Holdings Limited compare | — |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on LQDA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement